(Q48209812)

9 February 2018

title

Intratumoral T cell subset ratios and Fas ligand expression on brain tumor endothelium. (English)

1 reference

9 February 2018

0 references

1 reference

John S Yu

1

1 reference

9 February 2018

Paul K Lee

2

1 reference

9 February 2018

Moneeb Ehtesham

3

1 reference

9 February 2018

Ken Samoto

4

1 reference

9 February 2018

Keith L Black

5

1 reference

9 February 2018

Christopher J Wheeler

6

1 reference

9 February 2018

publication date

1 August 2003

1 reference

9 February 2018

Journal of Neuro-Oncology

published in

1 reference

9 February 2018

volume

64

1 reference

9 February 2018

issue

1-2

1 reference

9 February 2018

page(s)

55-61

1 reference

9 February 2018

https://scigraph.springernature.com/pub.10.1007/bf02700020

exact match

0 references

cites work

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

1 reference

12 December 2020

The dual functions of fas ligand in the regulation of peripheral CD8+ and CD4+ T cells

1 reference

12 December 2020

The role of Fas and related death receptors in autoimmune and other disease states

1 reference

12 December 2020

Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases

1 reference

12 December 2020

Immunobiology of primary intracranial tumors. Part 5: Correlation of a lymphocyte index and clinical status.

1 reference

12 December 2020

Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

1 reference

12 December 2020

Immunobiology of primary intracranial tumors. Part 1: studies of the cellular and humoral general immune competence of brain-tumor patients

1 reference

12 December 2020

Tumor-infiltrating lymphocytes in patients with metastatic melanoma receiving chemoimmunotherapy

1 reference

12 December 2020

The Fas counterattack: cancer as a site of immune privilege

1 reference

12 December 2020

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

1 reference

12 December 2020

Human melanoma cells do not express Fas (Apo-1/CD95) ligand

1 reference

12 December 2020

Reversed CD4/CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma.

1 reference

12 December 2020

Molecular biology and function of CD4 and CD8

1 reference

12 December 2020

Regulation of apoptosis in the immune system

1 reference

12 December 2020

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

1 reference

12 December 2020

Fas ligand-deficient mice display enhanced leukocyte infiltration and intima hyperplasia in flow-restricted vessels

1 reference

12 December 2020

Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes

1 reference

12 December 2020

Relationship of lymphocyte invasion and survival of brain tumor patients

1 reference

12 December 2020

1 reference

12 December 2020

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

1 reference

12 December 2020

Inflammatory leukocytes associated with increased immunosuppression by glioblastoma

1 reference

12 December 2020

Down-Regulation of CD25 Expression on the Surface of Activated Tumor-Infiltrating Lymphocytes in Human Cervical Carcinoma

1 reference

12 December 2020

TNFalpha regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation

1 reference

12 December 2020

T-cell markers in tumor-infiltrating lymphocytes of head and neck cancer

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02700020

1 reference

9 February 2018

PubMed ID

12952286

1 reference

9 February 2018